(Q84650982)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20682660%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20682660%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Elevated Serum Interleukin 33 Is Associated with Autoantibody Production in Patients with Rheumatoid Arthritis (English)

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

16 June 2024

1 reference

Rong Mu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20682660%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

He-Qing Huang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20682660%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Yu-Hui Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20682660%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Chun Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20682660%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Hua Ye

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20682660%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Zhan-Guo Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20682660%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

English

0 references

publication date

3 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20682660%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Rheumatology

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20682660%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20682660%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20682660%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

2006-2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20682660%20AND%20SRC:MED&resulttype=core&format=json

Evidence that cytokines play a role in rheumatoid arthritis

9 February 2020

cites work

1

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Cytokines in the pathogenesis of rheumatoid arthritis

16 June 2024

3

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Cytokines as therapeutic targets: advances and limitations

16 June 2024

4

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Evidence for activated peripheral blood T-cells in rheumatoid arthritis

16 June 2024

5

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

T cell homeostasis in patients with rheumatoid arthritis

16 June 2024

6

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses.

16 June 2024

7

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

B cells in rheumatoid arthritis.

16 June 2024

8

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Cytokine pathways and joint inflammation in rheumatoid arthritis

16 June 2024

9

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis

16 June 2024

10

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

IgG2b inducing factor from rheumatoid arthritis synovial fluid synergizes with transforming growth factor-beta in promoting IgG2b antibody production in mouse B lymphocytes

16 June 2024

12

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics

16 June 2024

14

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

16 June 2024

15

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex

16 June 2024

16

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

16 June 2024

17

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

IL-33 exacerbates antigen-induced arthritis by activating mast cells

16 June 2024

18

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis

16 June 2024

19

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis

16 June 2024

20

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

16 June 2024

21

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules

16 June 2024

22

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis.

16 June 2024

23

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

16 June 2024

IL-33 raises alarm

24

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Active caspase-1 is a regulator of unconventional protein secretion

16 June 2024

25

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

The inflammasome: first line of the immune response to cell stress

16 June 2024

26

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases.

16 June 2024

27

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Interleukin-33 is biologically active independently of caspase-1 cleavage

16 June 2024

28

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

16 June 2024

29

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells

16 June 2024

30

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

16 June 2024

31

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

IL-33 can promote survival, adhesion and cytokine production in human mast cells

16 June 2024

32

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals

16 June 2024

33

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells

16 June 2024

34

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells

16 June 2024

35

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

A novel IL-1 family cytokine, IL-33, potently activates human eosinophils

16 June 2024

36

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.

16 June 2024

37

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.

16 June 2024

38

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

HMGB1 is a potent trigger of arthritis

16 June 2024

39

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

NF-kappaB-dependent lymphocyte hyperadhesiveness to synovial fibroblasts by hypoxia and reoxygenation: potential role in rheumatoid arthritis

16 June 2024

40

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients

16 June 2024

41

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope

16 June 2024

42

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Clinical significance of anti-CCP antibodies in rheumatoid arthritis

16 June 2024

43

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Diagnostic performance and predictive value of rheumatoid factor, anti-citrullinated peptide antibodies, and the HLA shared epitope for diagnosis of rheumatoid arthritis

16 June 2024

44

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region

16 June 2024

45

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Mast cells: a cellular link between autoantibodies and inflammatory arthritis

16 June 2024

46

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1

16 June 2024

47

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

IL-33 exacerbates autoantibody-induced arthritis

16 June 2024

48

1 reference

https://api.crossref.org/works/10.3899/JRHEUM.100184

16 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20682660%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference